The Global Smart Medical Devices Market is dynamic and
is expected to witness healthy growth according to a report by Market Research
Future. Biotech companies have identified this demand and are working toward
catering to it by increasing investments toward the development of more
efficient methods of self-administration of drugs. Patient-centric biologics
and the growing participation of patients in their treatments have
significantly increased the demand for Smart Medical Devices. This represents
high potential for the development of treatment to pharmaceutical companies
which are increasingly submitting drug approvals for biologics which is
expected to be a significant driver of the Smart Medical Devices market.
Majority of large volume injectibles are presently
administered via IV which require close monitoring in a clinical setting, and
the ongoing nature of such drug administration has led to a demand for Smart
Medical Devices. Reducing the need to visit a hospital and or appointments, self-administration
in the comfort of one's own home is a highly attractive concept to patients
with chronic diseases and is an important factor driving the demand for Smart
Medical Devices.
Segmental Analysis
For the scope of research, MRFR's report offers a detailed
segmental analysis of the global Smart Medical Devices market
By Type
- On-body (adhesive patch)
- Off-body (belt clip)
- Hand-held
By Technology
- Spring-based
- Motor-driven
- Rotary Pump
- Expanding Battery
- Pressurized Gas
- Collapsible Reservoir
- Others
By Application
- Oncology
- Diabetes
- Auto-Immune Disorders
- Cardiovascular Diseases
- Infectious Diseases
- Others
By End-Use
- Hospital
- Clinic
- Home Care Settings
- Ambulatory Surgery Centers
- Others
By Region
- North America
- Europe
- Asia Pacific
- Rest of the world
Key Players
Market players of note in the global
Smart Medical Devices market include Unilife Corporation, Johnson & Johnson
Services, Inc., Debiotech S.A., Enable Injections, Sensile Medical AG, Becton
Dickinson and Company, F. Hoffmann-La Roche Ltd., Amgen Inc., West
Pharmaceutical Services Inc., Insulet Corporation, CeQur SA, and SteadyMed
Therapeutics, Inc.
Regional Analysis
North America is a significant
region due to the high prevalence of lifestyle diseases caused by excessively
sedentary lifestyles, and poor dietary habits. The region includes the U.S
which is home to a number of market players leading the Smart Medical Devices
market. The presence of a well-established healthcare sector with rising
expenditures and government support for the development of advanced
therapeutics for cancer, diabetes and other chronic diseases are expected to
drive the regional market.
The Asia Pacific has a high diabetic
population and a large patient population suffering from cardiovascular issues.
Moreover, the presence of a truly significant patient population among which
the geriatric demographic is considerable, thus making it a potentially
lucrative market for the Smart Medical Devices market. Governments in the
region are increasing their support of the healthcare sector, and rising
investments are expected to be conducive to the adoption of Smart Medical
Devices. Moreover, the increasing, rising disposable of the population combined
with increased awareness about advancements in healthcare technology are
expected to drive demand and as a result, market growth
Browse
Complete Report Details @ https://www.marketresearchfuture.com/upcoming-reports/smart-medical-devices-market-6493
About
US:
Market Research Future
(MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact
Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone:
+1
646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment